Back to library
LongevitySubcutaneous
Pinealon
Also known as: Glu-Asp-Arg · Khavinson tripeptide
Synthetic tripeptide (Glu-Asp-Arg) developed by the Khavinson lab as a short-peptide bioregulator. Penetrates the nucleus and may regulate gene expression in neural and aging-related pathways. Russian animal data suggest neuroprotection against oxidative stress.
At a glance
- Half-life
- 30 minutes
- Common route
- Subcutaneous
- Typical dose range
- 200–1,000mcg
- Stability (reconstituted)
- 14days refrigerated
Best timing
Daily for 10–20 day courses, then off. Often dosed AM. Russian protocols repeat 1–2x per year.
Contraindications
- Pregnancy
- Active cancer (epigenetic regulators are theoretical concern)
- Limited Western research — most studies are Russian-language
Watch symptoms
- Few reported adverse effects in animal studies
- Injection site reactions
- Limited human safety data
Citations